Renal Denervation with Symplicity Spyral Catheter - August 14th 2024
Case and Plan: 33-year-old male referred for resistant hypertension complicated by multiple hypertensive crises despite guideline-directed antihypertensive therapy. PMHx: Resistant HTN, HLD, NIDDMII, obesity s/p bariatric surgery, CKD Stage II 2/2 diabetic nephropathy Social Hx: Never smoker Medications: Hydralazine, Carvedilol, Lisinopril, HCTZ, Atorvastatin, Pantoprazole

▶︎
CFT for Coronary Microvascular Dysfunction(CMD) Vasospastic Angina(VSA) and Other Endotypes of ANOCA

▶︎
🩸Phlebotomy Certification Practice Test – 50 Questions to Help You PASS!

▶︎
Debate: Sympathetic Denervation - The case against- Darrel Francis

▶︎
Symplicity Spyral renal denervation: more insights from clinical practice - EuroPCR 2025

▶︎
Former nurse speaks out after sentencing in fatal drug error | Nightline

▶︎
The Professor Who Taught People How To Think (1962)

▶︎
Single Shot PVI With Balloon-in-Basket Technology | RIO 2024 US Focus

▶︎
#8: CFT for Coronary Microvascular Dysfunction (CMD), Vasospastic Angina (VSA) & Endotypes of ANOCA

▶︎
The science behind RF renal denervation safety and durability

▶︎
LRR Microbiology for FMGE 2026 By Dr. Preeti Sharma

▶︎
What's the deal with the Iran deal? | feat. Lt. Col. (Ret.) Jonathan Conricus & Behnam Ben Taleblu

▶︎
RDN Effectiveness in CKD Patients

▶︎
Evoque TTVR for a Patient with Recurrent Heart Failure and High Surgical Risk
![[TCTAP 2024] Live Case 1: Left Main & Complex PCI](https://i.ytimg.com/vi/uUIVLcd1988/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLDreXtXGzzXoCKEB-17nh2iIITrzA)
▶︎
[TCTAP 2024] Live Case 1: Left Main & Complex PCI

▶︎
CNS Infections | Clinical Medicine

▶︎
Living With A Pacemaker (common questions answered) - in Plain English!

▶︎
Renal Denervation for Treating Hypertension | Houston Methodist

▶︎
The turning point in hypertension care: Symplicity Spyral renal denervation in practice - EuroPCR

▶︎
Can Transcatheter Technology Approach Native Valve Physiology? | TIO 2026 US Focus

▶︎
